Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.
Onco Targets Ther. 2023 Jul 18;16:585-613. doi: 10.2147/OTT.S272563. eCollection 2023.
Onco Targets Ther. 2023.
PMID: 37485307
Free PMC article.
Review.
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives.
Cognigni V, Pecci F, Lupi A, Pinterpe G, De Filippis C, Felicetti C, Cantini L, Berardi R.
Cognigni V, et al. Among authors: felicetti c.
Cancers (Basel). 2022 Sep 29;14(19):4765. doi: 10.3390/cancers14194765.
Cancers (Basel). 2022.
PMID: 36230686
Free PMC article.
Review.
Item in Clipboard
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Parisi A, Giampieri R, Mammarella A, Felicetti C, Salvatore L, Bensi M, Maratta MG, Strippoli A, Filippi R, Satolli MA, Petrillo A, Daniele B, De Tursi M, Di Marino P, Giordano G, Landriscina M, Vitale P, Zurlo IV, Dell'Aquila E, Tomao S, Depetris I, Di Pietro FR, Zoratto F, Ciardiello D, Pensieri MV, Garrone O, Galassi B, Ferri C, Berardi R, Ghidini M.
Parisi A, et al. Among authors: felicetti c.
Front Oncol. 2022 Aug 12;12:935826. doi: 10.3389/fonc.2022.935826. eCollection 2022.
Front Oncol. 2022.
PMID: 36033477
Free PMC article.
Item in Clipboard
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.
Liguori C, Copparoni C, Felicetti C, Pecci F, Lupi A, Pinterpe G, Berardi R, Giampieri R.
Liguori C, et al. Among authors: felicetti c.
Curr Oncol. 2023 Jan 11;30(1):1032-1045. doi: 10.3390/curroncol30010079.
Curr Oncol. 2023.
PMID: 36661728
Free PMC article.
Item in Clipboard
Cite
Cite